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Fibronectins are large glycoproteins that have been implicated 
in  a  wide  variety  of cellular  properties,  particularly  those 
involving the interactions of cells with extracellular materials. 
These properties include cell adhesion, morphology, cytoskel- 
etal organization, migration, differentiation, oncogenic trans- 
formation, phagocytosis, and hemostasis. During the past sev- 
eral years, investigations in many laboratories have analyzed 
the expression, functions, and structure of fibronectins. These 
studies have revealed that fibronectins have a complex molec- 
ular structure consisting of multiple specific binding sites, and 
the complex biological phenomena in which fibronectins par- 
ticipate can now be considered in terms of this structure. 
In this brief article we will review the current understanding 
of  the  structure  and  properties  of  fibronectins.  Because  a 
number of comprehensive reviews on various aspects of fibro- 
nectins have been published (1-13), we shall focus on overall 
concepts, recent developments and promising future research 
directions in this rapidly expanding field. 
Sources of Fibronectins 
In vivo, fibronectins are found in body fluids (300 #g/ml in 
plasma, lesser amounts in other fluids), soft connective tissue 
matrices,  and  most  basement  membranes.  Fibronectins  are 
synthesized  by  a  wide  variety  of  cells  in  vitro  (Table  I). 
Fibroblasts and  endothelial  cells  are  major  producers,  but 
many other cell types, including some epithelial cells, synthe- 
size fibronectin at lower levels. There are at least two types of 
fibronectin, termed plasma and cellular fibronectins, although 
there may well be multiple forms of cellular fibronectin. Cel- 
lular and  plasma  fibronectins, although  distinguishable, are 
very similar in structure and properties (see below). One major 
source  of plasma fibronectin appears to  be hepatocytes (14, 
15) x  although  endothelial  cells  (16-18)  and  macrophages 
(19-22) could also contribute, given their close association with 
the bloodstream. 
This work was presented  in a symposium on Fibronectin and Other 
Cell Anchorage  Proteins  at the Twenty-first  Annual Meeting of the 
American Society for Cell Biology (Anaheim,  California, November 
1981). 
Wherever reference  15 appears, it refers to a paper by Tamkun,  J. 
W., and R. O. Hynes, submitted for publication. 
Properties of Fibronectins 
The basic properties of fibronectins are listed in Table II. 
The  molecule is  asymmetric and  consists of two  similar or 
identical subunits of molecular weight 220,000 +__ 20,000 daltons 
held together by disulfide-bonding near their carboxyl termini. 
Biophysical measurements indicate that, although the molecule 
as a  whole is flexible, it contains compact globular domains 
(23, 24). Electron microscopic results confirm the idea that the 
molecule is extended and flexible (25-27), although the glob- 
ular domains have not yet been observed by this technique. 
One important characteristic of fibronectins is that they are 
capable of interacting specifically with a wide variety of other 
macromolecules. Table III lists the various interactions, some 
of which have been studied in more detail than  others. The 
best-established interactions, for which evidence exists both for 
their occurrence in vivo and for their specificity in vitro, are 
the interactions with gelatin and collagens, fibrin, factor XIIIa 
transglutaminase, heparin, and proteoglycans. In addition, it is 
clear that fibronectins interact with many cells; however, the 
molecular basis for this interaction remains unclear and is one 
of the  major unanswered  questions  concerning fibronectins. 
The  binding sites on  fibronectins involved in many of these 
interactions have been identified and isolated, as will be dis- 
cussed in a later section. 
Although plasma fibronectin exists as a soluble protein, the 
typical appearance of cellular fibronectin is as a fibrillar extra- 
cellular matrix.  The  fibrils  containing  fibronectin  can  also 
contain  collagens  (28,  29)  and  proteoglycans (30-32).  It  is 
possible that interactions between fibronectin and other matrix 
molecules are important in the formation of these fibrils. The 
detailed molecular interactions involved in the formation of 
extracellular matrices and basement membranes  are another 
area of active research. 
FUNCTIONS OF FIBRONECTINS 
Table IV summarizes the cellular properties in which fibronec- 
tins have been implicated. The most thoroughly studied, and 
perhaps most basic, function of fibronectins is in the adhesion 
to solid substrates. Numerous studies have reported that fibro- 
nectins promote the adhesion and/or spreading of cells on a 
variety of materials including plastic, collagen, gelatin, and 
fibrin (33-36).  Cells that synthesize their own fibronectin do 
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Fibronectin Synthesis In Vitro* 
Cell type  Comments 
Fibroblasts 
Endothelial cells 
Chond  rocytes 
Myoblasts &  myotubes 
Macrophages 
Hepatocytes 
Amniotic cells 
Glial cell lines 
Intestinal epithelial cells 
Mammary epithelial 
cells 
Teratocarcinomas 
Early embryonic tissues 
Often  decreased  after  oncogenic 
transformation 
High rate of synthesis, large proportion 
secreted in vitro 
Amount  correlates inversely with  dif- 
ferentiation 
Quantity  appears to  differ  according 
to source of cells; transformed cells 
have less; myotubes often have less 
than myoblasts 
All or most is secreted 
All  or most  is-secreted plasma  fibro- 
nectin 
Amniotic  FN  is more heavily glycosyl- 
ated 
Glial cells in vivo probably do not syn- 
thesize FN. 
Small amounts only 
Decreased on metastatic cells 
Changes with differentiation 
Cells from  all three germ  layers have 
been  reported  to  synthesize fibro- 
nectin. 
* Specific references can be found in earlier reviews (see 1, 4, 11, and 13 for 
summary tables with references) and in the text. 
TABLE  II 
Properties of Fibronectins* 
Subunits 
pl 
Carbohydrate 
Sulfhydryl groups 
Disulfide bonds 
Secondary structure 
Tertiary structure 
High order associations 
220,000 +  20,000-dalton chains in disul- 
fide-bonded dimer. 
3.5-6.3 
5-9% asparagine-linked complex oligo- 
saccharides. 
One or two in the C-terminal 30% 
~20  per subunit.  Intersubunit  bond(s) 
are very near C-terminal.  N-terminal 
25%  is  very  rich  in  intrachain  disul- 
fides. 
No a  helix, probably some 1~ structure. 
Asymmetric  and elongated with  globu- 
lar domains. 
Form  disulfide-bonded  complexes and 
fibrils. 
* Specific references can  be found  in  earlier  reviews (see 3, 4, and  12 for 
summary tables with references) and in the text. 
not require exogenous fibronectin for adhesion and spreading, 
but many cells that produce little or none will respond to added 
fibronectin.  Among these cells  are some oncogenically trans- 
formed cells that produce reduced quantities of fibronectin as 
a consequence of transformation (37, 38). 
Concomitant with the spreading induced by added fibronec- 
tin, cells often acquire highly ordered intracellular  micro  fila- 
ment bundles (38,  39).  Furthermore,  extracellular  fibrils that 
contain fibronectin are often observed to correspond in their 
arrangement with intracellular microfilament bundles (40-47). 
Fig. 1 shows examples of this phenomenon. These results,  and 
others, suggest that there may be some form of physical con- 
nection between the extracellular matrix and the intracellular 
cytoskeleton (10).  The  molecular basis  for this interaction is 
not understood as yet. However, the idea that the cytoskeleton 
and  the extracellular  matrix  are part  of a  continuous supra- 
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molecular assemblage has important implications for consid- 
erations  of the  effects  of extracellular  matrices  on  cellular 
behavior. 
Interestingly, oncogenic transformation causes a pleiotropic 
change  in  cellular  properties  including  reduced  adhesion, 
rounded morphology, and loss of cytoskeletal organization, as 
well as loss of flbronectin. Because all of these changes can, in 
some cases,  be reverted by addition of fibronectin (37-39), it is 
possible that they reflect a common effect of the transforming 
agent (48). Extensive studies have shown that loss of fibronectin 
is a  common, though not universal,  concomitant of transfor- 
mation (1-13).  The reasons  for the loss appear to vary, and 
include  reduced synthesis (49,  50),  reduced  binding (49-53), 
and increased rates of degradation (49, 54). Correlative studies 
suggest some association between loss of fibronectin and tu- 
morigenicity in vivo (e.g.,  55,  56)  but  exceptions have  been 
noted  (e.g.,  57,  58),  and  preliminary  studies  suggest  that  a 
better correlation may exist  between  loss of flbronectin  and 
acquisition of metastatic potential (59-61). Given the involve- 
ment of fibronectin in adhesion to extracellular matrices, effects 
on invasion and metastasis might be expected from alterations 
in this aspect of cellular function. 
In vitro experiments have shown that fibronectin will pro- 
mote  cell  migration  in  culture  (62,  63)  and  can  stimulate 
chemotaxis or haptotaxis  (64,  65).  This raises  the possibility 
that  fibronectin  might  promote  or  guide  cell  migration  in 
embryos and, indeed, fibronectin has been found in association 
with several areas of cell migration including avian gastrula 
(66), neural crest (67-70), area vasculosa (68), amphibian pri- 
mordial germ cells  (71),  and sea urchin primary mesenchyme 
(72, 73). Perhaps also related to an involvement in cell migra- 
tion is the stimulation by fibronectin ofneurite outgrowth from 
retinal  cell  aggregates  (74).  It  should  be  stressed  that  the 
TABLE  III 
Interactions of Fibronectins 
Selected references 
Gelatin, denatured collagens, collagens I-V  * 
Fibrin, fibrinogen  * 
Factor Xllla transglutaminase  * 
Heparin  * 
Proteoglycans  * 
Cells  * 
Bacteria  75, 76 
Actin  127 
DNA  137 
Hyaluronic acid  * 
Gangliosides  165, 166 
Asymmetric acetylcholinesterase  167 
Clq component of complement  77, 78, 79 
Thrombospondin  97 
* See text and reviews for specific references. 
TABLE IV 
Functions of Fibronectins* 
Cellular adhesion 
Cellular morphology and spreading 
Cytoskeletal (microfilament) organization 
Oncogenic transformation 
Cell migration/chemotaxis or haptotaxis 
Phagocytosis 
Hemostasis/t  h rom bosis 
Embryonic differentiation 
* Specific references for the various functions  are given in the text. F~GURE  1  Codistributionof fibronectin fibrils andactin microfilament bundles. (A and  B)  Double label immunofluorescence of 
NIL8  hamster cells arrested in  low serum  (cf.  reference 40),4  shows fibronectin  stain,  B shows actin staining of the same cells. 
Arrows mark some of the coincidences. (C and D)  Immunoperoxidase staining of fibronectin in Xenopus mesentery cell cultures. 
C  shows  peroxidase staining  of  fibronectin.  D  shows a  phase photograph of  the same field.  Actin  microfilament  bundles are 
cotinear with the fibronectin  (reprinted from  reference 71).  (E)  Immunoferritin  staining of fibronectin in tsSV40-hamster embryo 
fibroblasts at  nonpermissive temperature.  Figure shows an  oblique section  through  the base  of  the cell  with  fibronectin  fibril 
outside cell at left colinear with actin microfilament bundle inside cell at right (reprinted from reference 42).  (F)  Similar section of 
NIL8  hamster cells not  stained with  antibody.  Figure again  shows extracellular fibrils  colinear with  intracellular  microfilament 
bundles (picture courtesy of Irwin Singer). 
371 presence  of fibronectin  in  areas  of cell  migration  does  not 
prove that it is functionally involved, even less that it is the 
only relevant matrix component. 
A  functional role for fibronectin in phagocytosis was origi- 
nally suggested on the basis of in vivo results that showed that 
levels of plasma fibronectin correlated with the ability of an 
organism to clear particulate debris, especially gelatin-coated 
particles, from the circulation (5). It was suggested that fibro- 
nectin was acting as a "non-specific opsonin" for the reticulo- 
endothelial system. This suggestion became even more inter- 
esting with  the observation that  fibronectin binds to certain 
bacteria  (75,  76).  The  recently  reported  binding  of Clq  by 
fibronectin (77-79) might also be important in phagocytosis of 
antibody aggregates or fragments of cells lysed by complement. 
In vitro studies have shown that fibronectin will indeed pro- 
mote phagocytosis of gelatin-coated beads by certain macro- 
phages although heparin is required as a cofactor (21, 80-82). 
No detailed  studies  have yet shown fibronectin to act as an 
opsonin  for  bacteria.  Thus,  the  in  vivo  relevance  of  the 
"opsonic" activity of fibronectin remains unclear and is under 
active investigation.  One interpretation  of fibronectin-stimu- 
lated endocytosis is that it is simply a specialized form of cell 
spreading on a substratum with a small rather than an infinite 
radius of curvature. 
Another possible role of plasma fibronectin is in hemostasis 
and thrombosis. During coagulation, fibronectin is crosslinked 
to fibrin  by factor XIIIa transglntaminase  (83,  84).  Further- 
more, platelets contain intracellular fibronectin (85,  86),  pos- 
sibly in their a-granules,  and release it on activation (86-88). 
Activated platelets will also bind exogenous plasma fibronectin 
(50, 88, 89). Consequently, at the site of interaction of platelets 
with  endothelial  cell  basement  membrane,  there  are  three 
possible sources of fibronectin; plasma, basement membrane, 
and the platelets themselves. Because other adhesive proteins 
such as yon Willebrands factor and thrombospondin are also 
present  in  the  platelets,  the  basement  membrane  and  the 
plasma  (88,  90-94),  the  adhesion  of platelets  is  likely to be 
complex. The exact role of fibronectin in this process remains 
unclear but, under certain artificial in vitro conditions, fibro- 
nectin can promote the adhesion and/or spreading of platelets 
(50, 95, 97). Crosslinking experiments suggest that an interac- 
tion  between  fibronectin  and  thrombospondin  occurs  when 
platelets spread on solid substrata (97).  Thrombospondin has 
also been implicated in platelet aggregation (98, 99). 
Finally, fibronectin has been implicated in the regulation of 
several differentiation pathways. Fibronectin has been reported 
both to stimulate  myogenesis and to inhibit  myoblast fusion 
(100,  101) and to inhibit chondrogenesis (102-104). The pre- 
cursor cells of both the myogenic and chondrogenic lineage are 
fibronectin-positive, and there appears to be a loss of fibronec- 
tin during progression along these two differentiation pathways 
(103-108). Fibronectin has also been reported to inhibit mela- 
nogenesis  and  to  promote  adrenergic  differentiation  in  ex- 
planted  neural  crest  cells  (109,  110). Extracellular  matrices 
have long been thought to play important roles in development. 
Fibronectin has now joined collagens and proteoglycans as a 
candidate  for a  role  in  these  processes,  as  have  even  more 
recently discovered glycoproteins such as laminin and  chon- 
dronectin. Clearly the role of the various matrix constituents, 
singly and in combination, in various differentiative events will 
be an active area of research in the next few years. 
Fibronectins therefore appear to be involved in an almost 
embarrassingly large array of cellular functions. How can an 
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individual molecule perform so many functions? The following 
sections  review  our  current  understanding  of the  structure- 
function relationships of fibronectins. 
STRUCTURE AND  FUNCTIONAL  DOMAINS OF 
FIBRONECTINS 
As mentioned above, spectrophotometric and ultracentrifuga- 
tion experiments indicate that cellular and plasma fibronectins 
are elongated molecules composed of structured domains sep- 
arated by flexible,  extendable regions ofpolypeptide chain (23, 
24,  111). By electron microscopy, fibronectins are usually vis- 
ualized as slender, elongated molecules with regions of appar- 
ently increased flexibility (25,  26),  although they can appear 
more globular under certain conditions (27).  Variability also 
exists in the hydrodynamic radius, which is known to increase 
or decrease,  depending upon ionic strength (23).  A  unifying 
interpretation  of these  studies  is that fibronectins  are highly 
flexible molecules that can expand or contract depending upon 
the local environment. 
Flexible polypeptide regions of proteins such as fibronectin 
tend  to be  particularly  susceptible  to attack by a  variety of 
proteases. Proteases will cleave such regions to generate sepa- 
rate,  structured  domains of the  molecule  containing specific 
binding sites for ligands (e.g., collagen and heparin, see Table 
III). 
There are two approaches to purifying such structural do- 
mains from fibronectin or any molecule with binding sites.  In 
the  first,  specific  ligands  are  coupled  covalently  to  agarose 
beads and are poured into affinity columns. The fibronectin is 
allowed to bind to the column and then incubated with various 
proteases.  Under appropriate  conditions, the enzymes cleave 
the molecule into protease-resistant  domains.  After extensive 
washing of the column, the only regions that remain bound to 
the column are  domains  specific for binding to the  specific 
ligand. An alternative  approach is to pretreat the fibronectin 
with proteases, to inhibit the proteases with protease inhibitors, 
and to pour the entire digest over affinity columns. Specific 
protease-resistant domains then bind to the column, and other 
fragments  are  discarded.  These  two  approaches  have  been 
surprisingly successul in identifying and purifying a series of 
protease-resistant,  functional domains  of fibronectin  and  lo- 
cating  these  domains  and  other  structural  features  on  the 
molecule (112-132). Fig. 2 shows the current model based on 
these results. 
Collagen-binding  Domain 
The first domain of fibronectin to be isolated was the colla- 
gen-binding domain. This region of the molecule is ~30-40,000 
daltons  in  size,  and  can  be  produced  after  digestion  of the 
intact molecule with chymotrypsin, subtilisin,  thermolysin, or 
even the broad spectrum protease pronase (112,  114, 116, 117, 
119, 120, 124, 125). This region binds to collagen or to gelatin 
alTmity columns, yet cannot mediate cell interactions.  Larger 
fragments are produced by different proteolytic conditions and 
allow mapping of the collagen-binding domain near to but not 
at  the  amino-terminius  (112,  113, 115, 116, 118, 119, 120, 
122-125,  128-131). 
Cell-binding  Domain 
The cell-binding activity appears to require a separate region, 
the "cell-binding" region of fibronectin, that can be purified N  C 
__  v  $S  ii 
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FIGURE  2  A  current  working  model  for  the  modular structure  of 
fibronectins.  The  molecules are composed of elongated subunits 
linked by disulfide bonds near the carboxyl terminus. Some regions 
are extremely sensitive to proteolysis and are depicted as extended 
chains  (thin  lines).  Other  regions  are compact  and  globular and 
contain  specific  binding sites  for other molecules. Two protease- 
resistant domains (I  and II)  are well-defined and readily purified. 
The remainder of the molecule is less well-analyzed, but appears to 
contain regions that are relatively sensitive to proteolysis (constric- 
tions) and other less sensitive regions that can be isolated by virtue 
of  their  binding affinities.  The  locations  of  the different  binding 
sites on the molecule are indicated. See text for details. 
from among the fragments of the molecule that do not bind to 
collagen affinity columns (112,  116,  120, 125, 128, 129, 132). 
The cell-binding region of fibronectin can mediate the attach- 
ment and spreading of cells on simple plastic substrates, even 
though it  is inactive in mediating the attachment  of cells to 
collagen. A fragment of 15,000 daltons still retains a significant 
amount of the cell binding activity of the intact molecule, but 
does not bind to either collagen or heparin (132). This fragment 
has been isolated using a monoclonal antibody that blocks cell 
binding activity (132). Analyses of partial digests show that this 
15-kdalton fragment and the cell-binding site lie in the central 
part of the molecule (116,  120, 125, 128, 129, 132). 
Fibrin and Transglutaminase  Interaction Sites 
The  binding  of fibronectin  to  fibrin  from blood  may be 
important in the initial stages of wound healing (133).  Fibro- 
blasts involved in the healing process adhere particularly well 
to fibronectin cross-linked to fibrin by factor XIIIa transglu- 
taminase (35). Fibronectin binds to fibrin or to fibrinogen both 
via its  amino-terminal  domain  and  through  site(s)  near  the 
carboxyl terminus of the molecule (128,  134, 135). However, 
the transglutaminase-mediated  cross-linking appears to occur 
only at the amino-terminal domain to a glutamine residue of 
fibronectin  (119,  120, 128, 130, 136). Collagen  can  also  be 
cross-linked to fibronectin by transglutaminase (84). Although 
the  primary  noncovalent  binding  of collagen  occurs  at  the 
adjacent  collagen-binding domain, the covalent cross-linking 
occurs only to the adjacent amino-terminal domain (119). 
Several other interesting interactions are also mediated by 
the  amino-terminal  domain  of fibronectin.  This  region  also 
binds to the bacterium Staphylococcus aureus and to actin (76, 
127,  131). Although the physiological consequences of these 
latter  interactions  are  not yet known,  binding to fibronectin 
might promote phagocytosis of these materials  by the reticu- 
loendothelial system as discussed earlier.  DNA is also bound 
at multiple sites on fibronectin, but this interaction appears to 
be weak and  is  inhibited  by physiological concentrations of 
calcium (137,  138). 
HYNES 
Glycosaminoglycan-binding  Domains 
As  described  previously,  interactions  of fibronectin  with 
heparin and heparan sulfate may play important roles in the 
uptake of material by macrophages or in the structural orga- 
nization of the extracellular matrix (21, 30--32, 80-82, 138-143). 
When examined  in vitro,  the interactions of fibronectin and 
heparin appear to be complex, with at least two components of 
moderately high binding affinity (121). 
The results of proteolytic dissection of the fibronectin mol- 
ecule  to  identify  the  regions  that  bind  to  heparin  affinity 
columns  are  also  complex.  There  are  two  or  three  distinct 
regions  of  the  molecule  that  bind  to  heparin  (125,  126, 
128-131).  One binding site  is  located in the amino-terminal 
domain of the molecule (125,  128, 130, 131). Interaction of this 
domain with heparin can be modulated by physiological con- 
centrations of calcium (138)  and is inhibited  by 0.25  M  salt 
(130). 
A second binding site is located close to the carboxyl termi- 
nus  of the  molecule  (125,  128-131),  and  its  binding is  less 
sensitive  to  salt  (130)  and  is  insensitive  to  divalent  cations 
(138). The existence of these multiple heparin-binding domains 
on fibronectin, and their differing sensitivities to divalent cat- 
ions and salt  concentrations,  suggest that  the interactions  of 
fibronectin with even one ligand can be surprisingly complex 
and may be modulated by the local microenvironment. 
Fibronectin can also bind to the glycosaminoglycan hyalu- 
ronic acid, which could affect the interactions  of hyaluronic 
acid with  cells  or other extracellular  matrix  molecules  (121, 
140,  141). The  binding by cellular  fibronectin  is  kinetically 
complex and  of moderately high affinity (121).  Recent data 
suggest that fibronectin must exist as an aggregate in order to 
mediate efficient binding,  because nonaggregated cellular or 
plasma fibronectins coupled to affinity columns bind poorly to 
hyaluronic  acid  (144).  Because  of this  latter  property,  the 
binding region for hyaluronic acid has not yet been identified. 
Disulfides and Sulfhydryls 
Similar analyses of fragments of fibronectin have shown that 
the interchain disulfides connecting the subunits of the fibro- 
nectin dimer are very close to the carboxyl terminus (115,  118, 
120, 122, 145-147). Both the amino-terminal and the collagen- 
binding  domains  are  extremely  rich  in  intrachain  disulfides 
(ll3,  115, ll7,  118). The  amino-terminal  domain  contains 
almost  10% half cystine and probably contains  10 intrachain 
disulfides. These may be responsible for the compact protease- 
resistant structure of this domain. The intrachain disulfides of 
the collagen-binding domain are essential for binding to col- 
lagen (113,  115). Each subunit of fibronectin contains at least 
one sulfhydryl group (115,  120) located ~ 170,000 daltons from 
the amino-terminus (122)  and probably a second one further 
towards the carboxyl terminus (122,  148). 
If these  sulfhydryl  groups  are  alkylated,  the  binding  of 
fibronectin into the cell surface matrix is inhibited (115,  122). 
It is possible that these sulfhydryls are involved in the inter- 
molecular  disulfide  bonding  of fibronectin  either  to  other 
fibronectin molecules or to other cell surface constituents such 
as proteoglycans. 
Structure-Function Model of Fibronectin 
The current model for the structure of fibronectin based on 
these results postulates a series of protease-resistant structural 
AND  YAMADA  Fibronectins: Multifunctional Modular Glycoproleins  373 domains, each of which contains specific ligand-binding activ- 
ities  (Fig. 2). The existence of these multiple, specific domains 
on fibronectin can begin to explain how this molecule may act 
in  a  variety  of molecular  interactions.  Fibronectin  can  be 
viewed as a  molecule  that  interconnects  a  series  of cell and 
matrix components to form macromolecular complexes at the 
cell surface and in the extracellular matrix (Fig. 3). 
In addition, this model makes predictions about the require- 
ments for certain combinations of domains for specific func- 
tions. For example, cell-cell interactions would be expected to 
require a multivalent molecule to enable fibronectin molecules 
to bind to more than one cell. Monomeric fibronectin fragments 
do have greatly diminished activity in such an assay (114).  On 
the other hand,  the attachment of cells  to collagen would be 
expected  to  occur  with  even  simple  monomers  but  would 
require  two  different  binding domains.  As predicted,  mono- 
meric fragments  of 205,000 daltons  containing one cell- and 
one collagen-binding site  are high active (114). 
It will  be  of interest  to examine  the  requirements  for the 
different heparin-binding domains in the nonimmune opsonic 
activity of fibronectin  with  macrophages,  in  terms  of which 
domain is required  and whether the interaction can be medi- 
ated  by  a  monomeric fragment.  More  complex activities  of 
fibronectin  can also  be  examined  with  these  fragments.  For 
example,  the  ability  of fibronectin  to  promote  migration  of 
fibroblasts has been attributed to only the cell-binding region 
of the molecule (149,  150). 
Role of Fibronectin's  Carbohydrates 
Fibronectin contains ~5% carbohydrate, consisting solely of 
"complex" oligosaccharides linked to asparaginyl residues. The 
synthesis of these oligosaccharide residues on fibronectin can 
be inhibited by 95-98% with tunicamycin, a relatively specific 
inhibitor of glycosylation (151,  153). The resultant  nonglyco- 
sylated fibronectin is  secreted  in virtually  normal quantities, 
suggesting that the carbohydrate moieties play no role in the 
TABLE  V 
Plasma Versus Fibroblast Cellular FJbronectins 
Relative biological 
Action  activity* 
Cell attachment to collagen  1x 
Cell spreading on plastic  qx 
Uptake of particles by macrophages  lX 
Morphological effects on transformed cells  3-50x~ 
Hemagglutination  150-200x§ 
* Activity  of cellular fibronectin compared to plasma fibronectin. 
:l:Cellutar  fibronectin purified from cells  by urea extraction  shows 50-fold 
higher activity  than plasma fibronectin in this assay (158). Dimeric cellular 
fibronectin from fibroblast  culture  medium  is at  most two-  to threefold 
more active than  plasma fibronectin  (50). The differences  may lie in  the 
degree of polymerization. 
§ These values are for cell surface fibronectin (158). 
secretion of this glycoprotein (152).  However, the rate of turn- 
over of carbohydrate-free fibronectin is accelerated by two- to 
threefold, and this increased rate results in a threefold decrease 
in total quantities of fibronectin on the cell surface of tunica- 
mycin-treated chick fibroblasts (152). 
Isolated nonglycosylated fibronectin is unusually susceptible 
to various proteases (152,  154). The region of fibronectin that 
becomes the  most  susceptible  to proteolysis  is  the  collagen- 
binding region, which normally contains most of the carbohy- 
drate  residues  of glycosylated fibronectin  (154).  A  heparin- 
binding region of fibronectin that normally lacks carbohydrate 
has the same protease susceptibility in glycosylated or nongly- 
cosylated fibronectin (154). 
Interestingly, there is no evidence that the carbohydrate on 
fibronectin has any role in its known biological activities. For 
example,  the  additional  branching of oligosaccharides on fi- 
bronectin that accompanies neoplastic transformation has no 
effect on its  morphological activities (53),  and even the total 
absence of carbohydrates after tunicamycin treatment does not 
alter  four  other  biological  activities  of fibronectin  (153).  It 
therefore  appears  that  the  carbohydrates  on  this  molecule 
function primarily to stabilize specific regions against proteo- 
lytic attack and abnormal rates of turnover; this stabilization 
may also be one of the major functions of carbohydrates on 
other glycoproteins (155). 
FIGURE  3  Hypothetical  scheme  showing  fibronectin  acting  as  a 
ligand, connecting the cell to the extracellular matrix. An elonaged 
dimeric fibronectin molecule is depicted interacting through its N- 
terminal  domains  with  collagen  and  through  other  binding  sites 
with a heparin sulfate proteoglycan (PG) and with cells. (cf. Fig. 2). 
One or more free sulfhydryl  groups may also become involved in 
disulfide-bonding.  The  nature  of  the  cell  surface  binding  site  is 
unknown--it is depicted here as an integral membrane protein (1) 
but it could be a protein, a glycolipid, or an assemblage of several 
molecules. The figure also shows one possible form of transmem- 
brane  interaction  between  fibronectin  and  actin  microfilaments, 
involving a transmembrane "fibronectin receptor" and a molecule 
binding the microfilaments to the inner face of the membrane (2). 
Candidates for this role include vinculin, a-actinin and/or spectrin. 
Although  the  Figure is  consistent with  known  experimental data, 
the details are speculative. 
Cellular Versus  Plasma  Fibronectins 
Recent studies indicate that the cellular and plasma forms of 
fibronectin are structurally and functionally very similar, but 
not identical.  The model shown in Fig.  2 apparently applies 
for both forms. Table V compares the biological activities of 
purified  cellular  and  plasma  fibronectins  in  a  number of in 
vitro assays. The two forms of fibronectin are indistinguishable 
in their biological activities in assays involving cell interactions 
with  substrates  (156,  157), or in opsonic activity for macro- 
phages (82).  In contrast, the effects of these molecules on cell 
morphology and  alignment  of transformed  cells  and  on  he- 
magglutination are sometimes substantially different; in these 
assays,  cellular  fibronectin  can  be  more  active  than  plasma 
fibronectin (50,  157). 
Biochemical studies have also revealed both similarities and 
differences  between  the  two  molecules.  The molecules  have 
very similar amino acid compositions, carbohydrate structures, 
and secondary and  tertiary  structures.  In addition,  the  types 
and the organization of specific structural domains are indis- 
tinguishable.  Nevertheless, plasma and fibroblast fibronectins 
have differences in pI (15), solubility (23, 24,  111), numbers of 
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subtle differences in the apparent size of specific domains (113, 
131). Any of these differences might be related to the biological 
differences.  An interesting finding in this regard is that  the 
regions of apparent difference between the two forms can be 
mapped to the interior of the molecules, rather than to an end 
(131,  161). This finding appears to rule out the previous most 
popular hypothesis that the two forms are related by simple 
proteolytic processing of one form to the other.  Monoclonal 
antibodies provide independent evidence that  the two  forms 
are distinct, because monoclonal antibodies have been found 
that bind preferentially to cellular as compared with plasma 
fibronectin (161, 162). One of these distinguishing monoclonals 
binds a determinant located near to the carboxy-terminal end 
but internal to the interchain disulfide bonds and its binding 
does not appear to require the presence of carbohydrate (161). 
This suggests the existence of differences in primary sequence. 
These studies indicate that although the two forms of fibro- 
nectin are very similar, they are structurally and functionally 
distinct. It will be of considerable interest to determine whether 
the two forms are the product of two or more distinct genes, or 
whether they are encoded by a  single gene that produces an 
RNA that is differentially processed to produce mRNA's en- 
coding either cellular or plasma fibronectins. 
CONCLUSIONS AND FUTURE PROSPECTS 
Analysis of the  structure  of fibronectins reveals a  modular 
structure that appears well suited for functioning as an adhesive 
ligand-like molecule. Fig. 3 shows one current view of fibro- 
nectin in the role of a  cell-matrix ligand and also depicts the 
possible relationship  with  intracellular  microfilaments.  Ob- 
viously, several features of this model remain uncertain. How- 
ever,  the  general  picture  of  a  molecule  with  binding  sites 
specific for some cell surface molecule(s) connected to other 
binding sites specific for various extraceUular moieties is well- 
founded  on  experimental data.  Furthermore,  some  form  of 
relationship with intracellular microfilaments is in accord with 
current data (10,  38-48), although the molecular basis for the 
transmembrane relationship remains unknown. 
This picture of an involvement of fibronectin in a connection 
between the cytoskeleton and the extracellular matrix, and in 
cellular interactions with  this matrix, suggests plausible and 
testable hypotheses to explain the roles played by fibronectins 
in the various cellular properties discussed earlier (Table IV). 
The challenge now is to test these hypotheses and resolve the 
unanswered questions. 
Although much is known about the structure (Fig. 2), not all 
the interactions of fibronectin (Table III) can yet be assigned 
to  specific locations within  the  molecule, and  the  details of 
many of the interactions remain to be analyzed. Further work 
along the lines discussed earlier should provide much of this 
information.  Detailed  structural  studies  (primary  sequence, 
biophysical measurements) on the individual domains should 
be available in the near future. Acquisition of  primary sequence 
data will be greatly aided by nucleic acid cloning studies now 
in progress. Detailed protein structural and nucleic acid anal- 
yses will also provide further  insight into  the  nature  of the 
differences between plasma and cellular fibronectins and the 
possibility of multiple forms of fibronectin. 
The modular structure of fibronectin lends itself well to the 
development  of  antibodies  specific  for  different  functional 
regions. Several monoclonal antibodies are already available 
(132,  161, 162),  as  well as  some  domain-specific polyclonal 
antisera (112,  163, 164). In the future, these reagents should be 
useful for investigating which local domains and binding sites 
function  in which  of the  more complex biological functions 
(Table  IV).  The  combination  of a  detailed  analysis of the 
structure of fibronectins with the development of antibodies 
able to interfere with specific functions should provide a clear 
picture of the structure-function relationships of these complex 
proteins. 
Two important properties of fibronectin that remain enig- 
matic are its ability to form fibrils and its interaction with cells. 
Analysis by chemical cross-linking, antibodies, and other tech- 
niques should allow identification of the cell surface binding 
site(s) and of the arrangement of fibronectin and other mole- 
cules in the fibrils. 
The  suggested roles of fibronectins in  complex biological 
phenomena  such  as  cell  migration,  cellular  differentiation, 
hemostasis and thrombosis, reticuloendothelial clearance, and 
cancer all require much more extensive investigation. Studies 
of these phenomena in vivo will be contingent upon progress 
on the biochemical, immunological, and cell biological analyses 
of fibronectins.  Furthermore,  because  fibronectins undoubt- 
edly interact in vivo with other molecules (collagens, proteo- 
glycans), these  other constituents will have  to  be  studied in 
parallel. It also seems clear that several other proteins of a type 
similar to fibronectins also function as cell-matrix ligands (eg, 
laminin,  chondronectin,  von  Willebrands  factor,  thrombo- 
spondin) and this list is likely to grow rapidly. The complex 
interaction among these various molecules are likely to provide 
a fertile field for research in the next few years, as they have in 
the last several. 
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